Camzyos

Active Ingredient(s): Mavacamten
FDA Approved: * April 28, 2022
Pharm Company: * MYOKARDIA INC
Category: Heart (Cardiac)
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Camzyos 2.5 mg Oral Capsule, Gelatin Coated
NDC: 73625-111
Labeler:
Myokardia, Inc.
Camzyos 5 mg Oral Capsule, Gelatin Coated
NDC: 73625-112
Labeler:
Myokardia, Inc.
Camzyos 10 mg Oral Capsule, Gelatin Coated
NDC: 73625-113
Labeler:
Myokardia, Inc.
Camzyos 15 mg Oral Capsule, Gelatin Coated
NDC: 73625-114
Labeler:
Myokardia, Inc.